Clinical Assessment of Safety and Tolerability of the New Monoclonal Humanized Antibody CaCP29
Clinical trial NCT01319903 · COMPLETED
Trial details
- NCT number
- NCT01319903
- Sponsor
- InflaRx GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2011-10-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.